Population Dynamics of Bank Voles Predicts Human Puumala Hantavirus Risk.


Journal

EcoHealth
ISSN: 1612-9210
Titre abrégé: Ecohealth
Pays: United States
ID NLM: 101222144

Informations de publication

Date de publication:
09 2019
Historique:
received: 29 11 2016
accepted: 15 05 2019
revised: 15 05 2019
pubmed: 17 7 2019
medline: 27 5 2020
entrez: 17 7 2019
Statut: ppublish

Résumé

Predicting risk of zoonotic diseases, i.e., diseases shared by humans and animals, is often complicated by the population ecology of wildlife host(s). We here demonstrate how ecological knowledge of a disease system can be used for early prediction of human risk using Puumala hantavirus (PUUV) in bank voles (Myodes glareolus), which causes Nephropathia epidemica (NE) in humans, as a model system. Bank vole populations at northern latitudes exhibit multiannual fluctuations in density and spatial distribution, a phenomenon that has been studied extensively. Nevertheless, existing studies predict NE incidence only a few months before an outbreak. We used a time series on cyclic bank vole population density (1972-2013), their PUUV infection rates (1979-1986; 2003-2013), and NE incidence in Sweden (1990-2013). Depending on the relationship between vole density and infection prevalence (proportion of infected animals), either overall density of bank voles or the density of infected bank voles may be used to predict seasonal NE incidence. The density and spatial distribution of voles at density minima of a population cycle contribute to the early warning of NE risk later at its cyclic peak. When bank voles remain relatively widespread in the landscape during cyclic minima, PUUV can spread from a high baseline during a cycle, culminating in high prevalence in bank voles and potentially high NE risk during peak densities.

Identifiants

pubmed: 31309365
doi: 10.1007/s10393-019-01424-4
pii: 10.1007/s10393-019-01424-4
pmc: PMC6858908
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-557

Subventions

Organisme : Svenska Forskningsrådet Formas
ID : 221-2012-1568
Pays : International

Références

Proc Biol Sci. 2006 Nov 7;273(1602):2771-6
pubmed: 17015326
Nature. 2008 Feb 21;451(7181):990-3
pubmed: 18288193
Proc Biol Sci. 2005 Oct 7;272(1576):2045-9
pubmed: 16191615
Ecology. 2007 Nov;88(11):2766-72
pubmed: 18051645
Virus Res. 2008 Oct;137(1):97-105
pubmed: 18620010
Philos Trans R Soc Lond B Biol Sci. 2012 Oct 19;367(1604):2807-13
pubmed: 22966136
Am J Trop Med Hyg. 2001 Mar-Apr;64(3-4):137-46
pubmed: 11442208
Emerg Infect Dis. 2009 Jan;15(1):104-6
pubmed: 19116065
Epidemiol Infect. 2010 Apr;138(4):576-84
pubmed: 19781114
Oecologia. 2016 Dec;182(4):1083-1093
pubmed: 27665542
Emerg Infect Dis. 2002 Sep;8(9):924-9
pubmed: 12194768
Oecologia. 1985 Oct;67(3):394-402
pubmed: 28311574
J Gen Virol. 2015 Jun;96(Pt 6):1238-47
pubmed: 25701819
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7039-44
pubmed: 26038558
Vector Borne Zoonotic Dis. 2005 Winter;5(4):305-14
pubmed: 16417426
Emerg Infect Dis. 2008 Aug;14(8):1209-15
pubmed: 18680643
PLoS Biol. 2006 Jun;4(6):e145
pubmed: 16669698
Ecohealth. 2012 Jun;9(2):205-16
pubmed: 22526751
J Gen Virol. 1999 Feb;80 ( Pt 2):371-9
pubmed: 10073697
Epidemiol Infect. 2002 Aug;129(1):147-53
pubmed: 12211582
Ecol Lett. 2006 Apr;9(4):467-84
pubmed: 16623732
Bioscience. 2015 Jul 1;65(7):651-666
pubmed: 26955081
Ecology. 2017 Mar;98(3):632-646
pubmed: 27935640
Vector Borne Zoonotic Dis. 2014 Sep;14(9):665-74
pubmed: 25229705
PLoS One. 2015 Jul 27;10(7):e0134124
pubmed: 26214509
Trends Ecol Evol. 2005 Jun;20(6):328-36
pubmed: 16701389
J Infect Dis. 1980 Feb;141(2):131-4
pubmed: 6102587
Rev Med Virol. 2013 Jan;23(1):35-49
pubmed: 22761056
Lancet. 2012 Dec 1;380(9857):1946-55
pubmed: 23200503
PLoS One. 2012;7(6):e39452
pubmed: 22745755
Trends Ecol Evol. 2001 Jun 1;16(6):295-300
pubmed: 11369107
Proc Biol Sci. 2001 Aug 22;268(1477):1741-8
pubmed: 11506689
Oecologia. 1978 Jan;32(2):141-152
pubmed: 28309394
Emerg Infect Dis. 2016 Jun;22(6):956-63
pubmed: 27070842
Proc Biol Sci. 2010 Dec 22;277(1701):3783-91
pubmed: 20591866
Emerg Infect Dis. 1998 Oct-Dec;4(4):529-37
pubmed: 9866729
J Reprod Fertil. 1986 Jan;76(1):83-9
pubmed: 3511257
Epidemiol Infect. 2011 Mar;139(3):381-90
pubmed: 20450527
Epidemics. 2009 Jun;1(2):101-7
pubmed: 21352757
Vector Borne Zoonotic Dis. 2014 Aug;14(8):537-51
pubmed: 25072983
Nature. 2008 Nov 6;456(7218):93-7
pubmed: 18987742
Sci Rep. 2016 Aug 08;6:31314
pubmed: 27499001
Emerg Infect Dis. 2003 Nov;9(11):1395-401
pubmed: 14718081
Science. 2013 Apr 5;340(6128):63-6
pubmed: 23559246
J Wildl Dis. 2003 Apr;39(2):299-305
pubmed: 12910756
Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Sep;70(3 Pt 1):030902
pubmed: 15524498
Vector Borne Zoonotic Dis. 2010 Aug;10(6):549-61
pubmed: 20795916
Am J Trop Med Hyg. 1995 Aug;53(2):134-40
pubmed: 7677213
Epidemiol Infect. 2009 Feb;137(2):250-6
pubmed: 18606026
Science. 2004 Apr 30;304(5671):736-8
pubmed: 15118163
PLoS One. 2014 Nov 12;9(11):e111663
pubmed: 25391132
Proc Biol Sci. 2014 Dec 22;281(1797):
pubmed: 25355481
Sci Rep. 2016 Feb 18;6:21323
pubmed: 26887639

Auteurs

Hussein Khalil (H)

Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, 901 83, Umeå, Sweden. Hussein.khalil@liverpool.ac.uk.

Frauke Ecke (F)

Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, 901 83, Umeå, Sweden.
Department of Aquatic Sciences and Assessment, Swedish University of Agricultural Sciences, P.O. Box 7050, 750 07, Uppsala, Sweden.

Magnus Evander (M)

Department of Clinical Microbiology, Virology, Umeå University, 901 85, Umeå, Sweden.

Göran Bucht (G)

Swedish Defense Research Agency, CBRN Defence and Security, Umeå, Sweden.

Birger Hörnfeldt (B)

Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, 901 83, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH